Cargando…

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series

Mostrar otras versiones (1)

BACKGROUND: Mechanically ventilated patients with COVID-19 have a mortality of 24–53%, in part due to distal mucopurulent secretions interfering with ventilation. DNA from neutrophil extracellular traps (NETs) contribute to the viscosity of mucopurulent secretions and NETs are found in the serum of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Andrew G., Chau, Alice S., Egeblad, Mikala, Barnes, Betsy J., Janowitz, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7522910/ https://www.ncbi.nlm.nih.gov/pubmed/32993479 http://dx.doi.org/10.1186/s10020-020-00215-w

Ejemplares similares

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

Comparison of Nebulized Epinephrine to Albuterol in Bronchiolitis
por: Walsh, Paul, et al.
Publicado: (2008)

The effects of ventilator settings, nebulizer and exhalation port positions on albuterol delivery during noninvasive ventilation: an in vitro study
por: Sutherasan, Y, et al.
Publicado: (2015)

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions
por: Kamin, Wolfgang, et al.
Publicado: (2007)

Effects of ventilator settings, nebulizer and exhalation port position on albuterol delivery during non-invasive ventilation: an in-vitro study
por: Sutherasan, Yuda, et al.
Publicado: (2017)

Bronchoscopy for foreign body aspiration and effects of nebulized albuterol and budesonide combination
por: Akcora, Bulent, et al.
Publicado: (2017)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
por: Toma, Andrew, et al.
Publicado: (2021)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis
por: Beck, Raphael, et al.
Publicado: (2007)

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
por: Okur, H.K., et al.
Publicado: (2020)

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
por: Holliday, Zachary M., et al.
Publicado: (2021)

Lactic acidosis and diastolic hypotension after intermittent albuterol nebulization in a pediatric patient
por: Saadia, Tehila A., et al.
Publicado: (2015)

Effect of nebulized eucalyptus on contamination of microbial plaque of endotracheal tube in ventilated patients
por: Amini, Nazanin, et al.
Publicado: (2016)

Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
por: den Hollander, Bibiche, et al.
Publicado: (2022)

Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer
por: McDermott, Kelly, et al.
Publicado: (2021)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
por: Pottecher, Julien, et al.
Publicado: (2020)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Response to first dose of inhaled albuterol in mechanically ventilated preterm infants
por: Raffay, Thomas M., et al.
Publicado: (2021)

High-dose versus low-dose nebulized albuterol in acute asthmatic attack: a randomized double-blind clinical trial
por: Hosseinnezhad, A, et al.
Publicado: (2005)

In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System
por: Berlinski, Ariel, et al.
Publicado: (2022)

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
por: Jiang, Chuan, et al.
Publicado: (2020)

Nebulized albuterol delivery is associated with decreased skeletal muscle strength in comparison with metered‐dose inhaler delivery among children with acute asthma exacerbations
por: Burger, Catherine, et al.
Publicado: (2021)

Significant Lactic Acidosis from Albuterol
por: Hockstein, Maxwell, et al.
Publicado: (2018)

Subcutaneous terbutaline as an alternative to aerosolized albuterol
por: Strauss, Ronald A.
Publicado: (2020)

Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Claudius, Casper, et al.
Publicado: (2015)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

USE OF ALTEPLASE AND DORNASE FOR LYSIS OF COVID-19-RELATED LOCULATED PLEURAL EFFUSION
por: STAIANO, PETER P, et al.
Publicado: (2022)

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn
por: Kim, Myo-Jing, et al.
Publicado: (2014)

Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
por: Shaker, Marcus S., et al.
Publicado: (2020)

Caught in the act: revealing the metastatic process by live imaging
por: Fein, Miriam R., et al.
Publicado: (2013)

Budesonide Nebulization in the Treatment of Neonatal Ventilator Associated Pneumonia
por: Li, Baoqiang, et al.
Publicado: (2017)

Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays
por: Sun, Lijuan, et al.
Publicado: (2022)

Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC
por: George, Mathew, et al.
Publicado: (2017)

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
por: Nakasone, Elizabeth S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qdie7snac9sr9vnal09b1md40r